www.fdanews.com/articles/102498-valeant-pharmaceuticals-sells-infergen-to-three-rivers
Valeant Pharmaceuticals Sells Infergen to Three Rivers
December 20, 2007
Valeant Pharmaceuticals International and Three Rivers Pharmaceuticals LLC jointly announced the signing of a definitive agreement in which Valeant will divest its U.S. and Canadian rights to its hepatitis C drug, Infergen, to Three Rivers.
StreetInsider.com
StreetInsider.com